CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Pars Plana Vitrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01319318
NCT01319318N/ACompleted
CompareCT.gov

Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy

Allergan·observational·Posted Mar 21, 2011·Updated Jul 2, 2013

In Brief

An observational study evaluating Pars Plana Vitrectomy for Vitrectomy. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVitrectomy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 21, 2011
Enrollment StartMar 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.3 years ago

Interventions

Pars Plana Vitrectomyprocedure

Pars plana vitrectomy performed in study eye on Day 0.